Advertisement

Topics

PDL BioPharma - Investing in Evofem

08:58 EDT 16 Apr 2019 | FinanzNachrichten

PDL announced that it will invest a total of up to $60m in two tranches of $30m each in Evofem, a women's health company that is preparing to submit an NDA for Amphora, a non-hormonal female contra...

Original Article: PDL BioPharma - Investing in Evofem

NEXT ARTICLE

More From BioPortfolio on "PDL BioPharma - Investing in Evofem"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...